Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
189.00    -3.60 (-1.87%)
Bid:
189.20
Ask:
190.60
Spread: 1.40 (0.74%)
Market Cap: £504.78m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Board changes

20 Nov 2013 07:00

RNS Number : 4534T
Costain Group PLC
20 November 2013
 



 

Costain Group PLC

("Costain" or the "Company")

Board Changes

Mr Samer Younis, a Non-Executive Director of Costain and the nominee of Mohammed Abdulmohsin Al-Kharafi & Sons Co. W.L.L. ("Kharafi"), has notified the Board of his resignation as a Director of the Company with effect from 30 November 2013.

 

Mr Ahmed Aly Samy, a nominee of Kharafi, has been appointed to the Board as a Non-Executive Director with effect from 30 November 2013. Mr Samy, the Deputy Director General of Investment Affairs at Kharafi, will also be a member of Costain's Nomination Committee.  

 

No information is required to be disclosed under LR 9.6.13 R(1)-(6).

 

David Allvey, Chairman, commented:

 

"Samer has made a significant contribution to Costain since joining the Board in 2009 and we wish him well for the future. We are pleased to welcome Ahmed as his replacement and the wealth of experience he will bring to the Board."

 

20 November 2013

 

ENQUIRIES:

Costain Group PLC

Tel: 01628 842444

Tracey Wood, Company Secretary

College Hill

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABLBRTMBBBBLJ
Date   Source Headline
24th Nov 201711:28 amRNSBoard Notification - External Directorship
23rd Nov 20172:48 pmRNSHolding(s) in Company
17th Nov 201710:13 amRNSAppointment of Non Executive Director
1st Nov 201711:21 amRNSDirector/PDMR Shareholding
1st Nov 201711:16 amRNSTotal Voting Rights
26th Oct 20177:00 amRNSBlock Listing Application
25th Oct 20172:22 pmRNSDirector/PDMR Shareholding
20th Oct 20173:42 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSDividend - Scrip Alternative
29th Sep 20177:00 amRNSGreater Manchester Waste contract
25th Sep 20172:21 pmRNSDirector/PDMR Shareholding
21st Sep 201710:10 amRNSScrip Dividend Reference Price
15th Sep 20179:39 amRNSHolding(s) in Company
4th Sep 201710:37 amRNSHolding(s) in Company
24th Aug 20177:00 amRNSGreater Manchester Waste contract
23rd Aug 20177:00 amRNSHalf-year Report
1st Aug 20177:00 amRNSContract
20th Jul 20178:45 amRNSHolding(s) in Company
17th Jul 20178:12 amRNSHigh Speed Two "minded to award" Costain contracts
13th Jul 201712:19 pmRNSRe: Directorate
4th Jul 20177:00 amRNSTrading Update
30th Jun 20179:00 amRNSBlock listing Interim Review
31st May 201712:00 pmRNSTotal Voting Rights
16th May 20177:00 amRNSDividend - Scrip Alternative
8th May 20174:55 pmRNSResult of AGM
8th May 20177:00 amRNSAGM Statement
2nd May 20174:37 pmRNSGreater Manchester Waste contract
28th Apr 20171:56 pmRNSTotal Voting Rights
26th Apr 20175:06 pmRNSHolding(s) in Company
13th Apr 201710:52 amRNSScrip Dividend Reference Price
6th Apr 20179:40 amRNSDirector/PDMR Shareholding
5th Apr 201710:02 amRNSHolding(s) in Company
4th Apr 20174:16 pmRNSHolding(s) in Company
3rd Apr 20173:41 pmRNSHolding(s) in Company
31st Mar 201710:07 amRNSTotal Voting Rights
24th Mar 20179:28 amRNSHolding(s) in Company
20th Mar 201712:22 pmRNSHolding(s) in Company
17th Mar 20177:00 amRNSNotice of AGM
14th Mar 20172:30 pmRNSHolding(s) in Company
13th Mar 201712:12 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSFinal Results
28th Feb 201710:56 amRNSTotal Voting Rights
31st Jan 20179:00 amRNSTotal Voting Rights
5th Jan 20177:01 amRNSAppointment to £500m Major Projects Framework
5th Jan 20177:00 amRNSTrading Update
3rd Jan 20178:00 amRNSTotal Voting Rights
3rd Jan 20178:00 amRNSBlock listing Interim Review
16th Dec 20167:00 amRNSContract
14th Dec 201610:00 amRNSTransfer of Shares
1st Dec 20169:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.